These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 10718027)
1. The industrialization of clinical research. Rettig RA Health Aff (Millwood); 2000; 19(2):129-46. PubMed ID: 10718027 [TBL] [Abstract][Full Text] [Related]
3. Barriers to clinical trial enrollment: are state mandates the solution? Hillner BE J Natl Cancer Inst; 2004 Jul; 96(14):1048-9. PubMed ID: 15265958 [No Abstract] [Full Text] [Related]
4. Prescription drugs and managed care: can 'free-market détente' hold? Moran DW Health Aff (Millwood); 2000; 19(2):63-77. PubMed ID: 10718023 [TBL] [Abstract][Full Text] [Related]
5. Patients, physicians, and clinical trials: the other side of the coins. Abramson SB; Flexner C; Snyderman R; Dieterich DT; Korn D; Temple R; Sherwood L; Goldblatt D J Investig Med; 1999 Sep; 47(8):343-57. PubMed ID: 10510587 [No Abstract] [Full Text] [Related]
7. [Biomedical research: private interests and public interests]. Martin J Sante Publique; 2001 Mar; 13(1):89-93. PubMed ID: 11525046 [No Abstract] [Full Text] [Related]
8. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry. Dorfman HL; Reig LP Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876 [No Abstract] [Full Text] [Related]
9. Making clinical trials safer for human subjects. Baram M Am J Law Med; 2001; 27(2-3):253-82. PubMed ID: 11467112 [No Abstract] [Full Text] [Related]
10. Biomedical ethics. Penn report, agency heads home in on clinical research. Marshall E Science; 2000 Jun; 288(5471):1558-9. PubMed ID: 10858125 [No Abstract] [Full Text] [Related]
11. Current issues surrounding women and minorities in drug trials. Wermeling DP; Selwitz AS Ann Pharmacother; 1993; 27(7-8):904-11. PubMed ID: 8364277 [TBL] [Abstract][Full Text] [Related]
12. Waivers proposed for emergency studies. Wolfgang L Science; 1995 Oct; 270(5233):25-6. PubMed ID: 7569946 [No Abstract] [Full Text] [Related]
13. Clinical trials integrity: a CRO perspective. Beach JE Account Res; 2001; 8(3):245-60. PubMed ID: 12481762 [TBL] [Abstract][Full Text] [Related]
14. Biotech and pharma face more costly clinical trials. Brower V Nat Biotechnol; 1998 Aug; 16(8):714. PubMed ID: 9702762 [No Abstract] [Full Text] [Related]
16. Protecting research subjects--what must be done. Shalala D N Engl J Med; 2000 Sep; 343(11):808-10. PubMed ID: 10984573 [No Abstract] [Full Text] [Related]
17. IRBs search for answers and support during a time of institutional change. Phillips DF JAMA; 2000 Feb; 283(6):729-30. PubMed ID: 10683041 [No Abstract] [Full Text] [Related]
18. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials. Lachin JM Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730 [TBL] [Abstract][Full Text] [Related]
19. America's other drug problem: how the drug industry distorts medicine and politics. Relman AS; Angell M New Repub; 2002 Dec; 227(25):27-41. PubMed ID: 12561803 [No Abstract] [Full Text] [Related]
20. Time for new rules on human subjects research? Dresser R Hastings Cent Rep; 1998; 28(6):23-4. PubMed ID: 9868606 [No Abstract] [Full Text] [Related] [Next] [New Search]